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Abstract 23 
One of the hallmark features of destructive periodontal disease, well documented over the last 50 24 
years, is a change to the quantitative and qualitative composition of the associated microbiology. 25 
These alterations are now generally viewed as transformational shifts of the microbial populations 26 
associated with health leading to the emergence of bacterial species which are only present in low 27 
abundance in health and a proportionate decrease in the abundance of others. The role of this 28 
dysbiosis of the health associated microbiota in the development of disease remains controversial: is 29 
this altered microbiology the driving agent of disease or merely a consequence of the altered 30 
environmental conditions which invariably accompany destructive disease? In this work we aimed to 31 
address this controversy through controlled transmission experiments in the mouse in which a 32 
dysbiotic oral microbiome was transferred either horizontally or vertically into healthy recipient mice. 33 
The results of these murine studies demonstrate conclusively that natural transfer of the dysbiotic 34 
oral microbiome from a periodontally diseased individual into a healthy individual will lead to 35 
establishment of the dysbiotic community in the recipient and concomitant transmission of the 36 
disease phenotype. The inherent resilience of the dysbiotic microbial community structure in diseased 37 
animals was further demonstrated by analysis of the effects of antibiotic therapy on periodontally 38 
diseased mice. Although antibiotic treatment led to a reversal of dysbiosis of the oral microbiome, in 39 
terms of both microbial load and community structure, dysbiosis of the microbiome was re-40 
established following cessation of therapy.  Collectively these data suggest that an oral dysbiotic 41 
microbial community structure is stable to transfer and can act in a similar manner to a conventional 42 
transmissible infectious disease agent with concomitant effects on pathology. These findings have 43 
implications to our understanding of the role of microbial dysbiosis in the development and 44 
progression of human periodontal disease. 45 
 46 
  47 
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Introduction 48 
The association between dysbiosis of the oral microbiome and periodontitis is now well 49 
established (Mira et al. 2017).  Although there are significant individual-to-individual variations in 50 
the microbial composition of subgingival biofilms in health (Hall et al. 2017), the development of 51 
disease coincides with a characteristic population shift. Consistently, the change involves not only 52 
an increase in the overall microbial biomass but also the emergence of bacterial species which are 53 
only present in low abundance in health and a proportionate decrease in the abundance of others 54 
(Marsh PD 1994, Socransky et al. 1998, Diaz et al. 2016).  Although culture-based studies originally 55 
indicated that the emergent bacterial populations in the disease-associated communities may 56 
represent only a relatively small number of different taxa (Holt & Ebersole 2005, Socransky et al. 57 
1998), the application of more advanced technologies has demonstrated that a wider range of 58 
organisms should be considered (Abusleme et al. 2013, Griffen et al. 2012). This in turn, has led to 59 
the concept of a community wide perturbation in the composition of the microbiome associated 60 
with periodontal disease (Hajishengallis & Lamont 2012, Curtis MA 2014). However, it remains 61 
controversial to what extent the observed shift in the microbial population structure in 62 
periodontitis is the primary cause of pathology or simply a consequence of the altered 63 
environmental conditions induced in an inflammatory disease. This dichotomy remains an 64 
important issue in terms of both diagnosis and treatment modalities of a range of conditions 65 
associated with dysbiosis in humans (Butto and Haller 2016). 66 
In previous studies, using a mouse model of periodontal disease, we demonstrated that the 67 
introduction of P. gingivalis into the oral microbiome of specific pathogen free (SPF) mice led to 68 
significant alterations in both the quantity and qualitative composition of the commensal 69 
microbial populations: analogous to the community wide perturbations observed in human 70 
disease (Hajishengallis et al. 2011). Similarly, the microbial shift was also associated with the 71 
development of destructive disease based on increased loss of alveolar bone in challenged mice.  72 
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In the present investigation, we aimed to use this mouse model of periodontitis, or more precisely 73 
controlled transmission experiments in mice, to address whether the microbial dysbiosis observed 74 
in this system following oral challenge with P. gingivalis represents a definitive pathological entity 75 
capable of transferring horizontally (from one mouse to another by co-caging) and vertically 76 
(between generations from parents to litter) to drive destructive disease.  77 
Materials and Methods 78 
Animals  79 
All animal experiments were conducted in accredited facilities in accordance with the UK Animals 80 
(Scientific Procedures) Act 1986 (Home Office license number 7006844). Germ-free C3H/Orl mice 81 
(Charles River Laboratories International) were maintained in isolators under axenic conditions at the 82 
Royal Veterinary College, University of London as previously described (Hajishengallis et al. 2011). 83 
Conventional C3H/Orl mice, derived from the original germ-free mice were maintained in individually 84 
ventilated cages (IVC) at the animal care facilities of Queen Mary University of London (QMUL).  The 85 
germ-free mice were bred and maintained in a separate location due to the highly specialist nature of 86 
their housing requirements.  87 
 88 
Oral Gavage and Microbiome Transfer Experiments  89 
P. gingivalis W50 was grown on blood agar plates containing 5% defibrinated horse blood or in Brain 90 
Heart Infusion broth (BHI) (Oxoid) supplemented with haemin (5 g/mL) in an anaerobic atmosphere 91 
of 80% N2, 10% H2 and 10% CO2 at 37oC (Don Whitley Scientific). Oral gavage with P. gingivalis was 92 
performed essentially as described by (Baker et al. 2000). Briefly, mice were orally inoculated by 93 
means of a ball-ended feeding needle three times at two-day intervals with 109 CFU P. gingivalis W50 94 
suspended in 2% carboxy-methylcellulose (Sigma) vehicle. Sham controls received vehicle alone.  95 
For the stability, vertical transmission and horizontal transmission experiments, six mice were used in 96 
the control and challenged cohorts at the beginning of the study. For the antibiotic experiment, five 97 
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mice were used in each cohort. In the stability experiment, after week 16, two mice from each group 98 
were used as breeders to generate litters to determine the efficiency of vertical transfer.  99 
For horizontal transfer experiments, germ-free mice were transported in sterile conditions to the SPF 100 
animal facility at QMUL and co-caging set up immediately in IVCs. Oral swabs were collected from the 101 
germ-free mice before co-caging to confirm sterility. Two challenged female SPF donor mice and four 102 
recipient germ-free animals were co-caged at a ratio of 1:2 in each cage for 16 weeks. The co-caging 103 
was commenced 10 days after the last P. gingivalis inoculation of the female SPF mice, which was also 104 
when oral dysbiosis was confirmed by microbial analysis.  105 
For the antibiotic experiment, a 2.5% solution of Septrin co-trimoxazole (GlaxoSmithKline) was 106 
provided in the drinking water of the mice for 10 days followed by a wash period of 4 days.  At the end 107 
of each experiment, mice were euthanized by the CO2 inhalation method.  108 
 109 
Cultural Microbiological analyses 110 
The murine oral cavity was sampled for 30 seconds using sterile fine tip rayon swabs (VWR 111 
International) and placed in a tube containing 100 µl reduced John’s transport medium. Serial dilutions 112 
of the suspension were spread onto blood agar plates for aerobic and anaerobic growth at 37oC. The 113 
colony forming units (CFU) of predominant cultivable bacteria on each plate were counted. Every 114 
different colony morphology type from each experimental group was isolated, purified by subculture 115 
and identified by full length 16S ribosomal RNA gene sequencing as described previously 116 
(Hajishengallis et al. 2011; Maekawa et al. 2014). On an average, 4-6 different colony types could be 117 
identified on each blood agar plate.  118 
 119 
Next generation sequencing using Roche 454 GS-FLX+ Titanium Pyrosequencer 120 
Whole genomic DNA was extracted from the above swabs using the GenElute Bacterial DNA Kit 121 
(Sigma-Aldrich). The extracted samples were used as templates in PCR reactions performed in 122 
Extensor Long PCR Reddymix MasterMix (Thermo Scientific) using primer 27FYM, extended at the 5’-123 
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end to include a 30-base 454 adaptor sequence A and a unique 12 nucleotide Golay barcode for each 124 
sample, and primer 519R which has a 5’- extension with a 30-base 454 adaptor sequence B (Kistler et 125 
al. 2013). The amplified PCR products were cleaned with the Qiaquick Kit (Qiagen). When necessary, 126 
primer dimers were removed with NucleoSpin Gel and PCR Clean-up (Fisher Scientific).  The amplicons 127 
were pooled in equimolar amounts prior to emulsion PCR, and unidirectionally sequenced using the 128 
Lib L v2 kit (Roche) on a Roche 454 GS-FLX+ Titanium sequencer. De-noising, de-multiplexing, 129 
trimming, chimera check, classification, clustering, Operational Taxonomic Units (OTUs) assignments, 130 
and further analyses were performed using the mothur pipeline (Schloss et al. 2009). The raw 131 
sequencing reads have been uploaded to the NCBI SRA database (Accession No. PRJNA543124).  132 
 133 
Periodontal bone loss determination 134 
Mice were euthanized as above, mandibles and maxillae were dissected, defleshed and assessed 135 
under a Stemi SV11 dissecting microscope (Zeiss) at 25x magnification. The captured images were 136 
analysed by ImageJ software (National Institute of Health, USA). The distance from the cemento-137 
enamel junction (CEJ) to the alveolar bone crest (ABC) was measured at 6 pre-determined points 138 
(mesio-, mid- and distal-) on both buccal and lingual/palatal surfaces of mandibular and maxillary 139 
molar teeth. In order to calculate bone loss, the mean CEJ-ABC distance from each test mouse was 140 
subtracted from the mean CEJ-ABC distance of the control mice, which was used a zero baseline 141 
(modified from Baker et al. 2000). 142 
 143 
Statistical Analyses  144 
Bone levels between different experimental groups were compared using one-way analysis of 145 
variance (ANOVA) and unpaired Student’s t-test between 2 comparison groups. Significance was 146 
expressed at the p<0.05 level (Hajishengallis et al., 2011). The statistical analyses and graphical 147 
visualization of the bone levels were performed using Graphpad Prism 7 (Graphpad Software Inc.). 148 
The differences in the composition of the overall microbiome between the treatment and control 149 
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groups at each time point in each experiment were assessed by PERMANOVA analyses using the 150 
Adonis function in the Vegan package in R (Dixon P 2003). Differences in the number of CFUs of 151 
individual bacterial genera between treatment and control groups were assessed by Welch’s t-test 152 
using Graphpad Prism 7.  153 
 154 
Results 155 
P. gingivalis mediated dysbiosis is stable over time and associated with long term destructive 156 
disease in the murine model 157 
Oral gavage with P. gingivalis resulted in a 10-fold increase in the total quantitative oral microbial load 158 
and a statistically significant (p<0.005) qualitative alteration to the composition of the oral 159 
microbiome at 7 days post challenge (Fig 1.). The dysbiotic microbiome generated by P. gingivalis 160 
challenge is referred to as DysPg throughout this manuscript. The predominant cultured organisms 161 
from unchallenged mice comprise representatives of the Streptococcus, Gemella and Staphylococcus 162 
genera. Following challenge, these genera were retained but members of the Enterobacteriaceae 163 
family and Lactobacillus genus also became major constituents. These changes were maintained over 164 
the course of the experimental period to 28 weeks. Microbial population analysis of these samples by 165 
next generation sequencing methodology revealed a similar pattern (Fig. 2).  In particular, the 166 
Streptococcus and Gemella genera were predominant in both control and challenged mice and 167 
lactobacilli became prominent members of the overall DysPg community by week 28. The main 168 
discrepancy between the two methods of analysis was in quantitation of Enterobacteriaceae 169 
particularly at week 16 where this genus represented approximately 40% of the total community by 170 
culture but only a minor constituent on the basis of non-cultural analysis. This under representation 171 
may be a reflection of the number of mouse oral taxa which are as yet unnamed and not adequately 172 
curated, resulting in a significant number of reads belonging to Gammaproteobacteria being grouped 173 
as unclassified. As previously described (Hajishengallis et al. 2011), we were unable to detect P. 174 
gingivalis by cultural analysis at any time point from oral swabs of challenged mice. This low 175 
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abundance was confirmed by non-cultural analyses where P. ginigivalis sequences could only be 176 
detected in less than one-third of the DysPg samples and at very low levels (0.013% of the total reads 177 
in each sample) (Fig 2.). A similar level of coherence between cultural and non-cultural techniques was 178 
observed in all the experiments reported here, and hence we only present data from cultural analyses 179 
in the following sections.  180 
Loss of periodontal bone was increased in the challenged mice in a linear manner over the entire 181 
experimental period of 28 weeks. The rate of bone loss in the challenged mice at 0.002 mm/week was 182 
approximately eight times higher (p<0.01) than the unchallenged mice. Thus, the presence of a DysPg 183 
oral microbiome is consistently associated with alveolar bone loss. 184 
P. gingivalis mediated dysbiotic microbiomes stably transfer horizontally into healthy germ-free 185 
mice and lead to periodontal disease in the recipients.  186 
In previous work, we demonstrated efficient transfer of the oral commensal microbiota from healthy 187 
control SPF C3H/Orl mice into germ-free mice of identical genotype accompanied by only low levels 188 
of physiological bone loss in the recipients. (Hajishengallis et al. 2011). Here we examined the stability 189 
on transfer of a DysPg microbiome into germ-free mice and the disease phenotype of the recipients. 190 
C3H/Orl mice challenged with P. gingivalis were co-caged in 1:2 ratio with germ-free C3H/Orl mice. 191 
After 14 days, the microbiology of the donor and recipient mice was shown to be not significantly 192 
different in terms of both the quantitative and qualitative composition (Fig 3). Thus, the differential in 193 
the total counts of control versus P. gingivalis challenged mice was maintained in the germ-free 194 
recipients of these two microbiomes. Furthermore, the elevated level of periodontal bone loss in the 195 
donor challenged mice (0.009 mm/week; p<0.0001) was also evident in the conventionalized mice 196 
that received the DysPg microbiome, after 16 weeks of co-caging (0.008 mm/week; p<0.0001). Hence, 197 
these experiments demonstrate a direct cause and effect of acquisition of the DysPg microbiome and 198 
the development of bone loss even though the recipient animals were not exposed to the high dose 199 
inoculum of P. gingivalis received by the donors. 200 
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Inter-generational transfer of P. gingivalis mediated dysbiotic microbiomes and vertical 201 
transmission of disease. 202 
The causal relationship of dysbiosis and periodontal disease was then further explored in vertical 203 
transmission experiments. Control or P. gingivalis challenged C3H/Orl mice were mated and the oral 204 
microbiology of the corresponding litters was compared at 8, 16 and 28 weeks of age, and the 205 
periodontal bone loss at 16 and 28 weeks (Fig 4). First generation animals acquired an oral microbiome 206 
similar in composition and total counts to the parent mice, with no statistical significance between the 207 
respective oral microbial populations. Thus, whilst control litter mice had oral counts of between 106-208 
107 CFU, the offspring of challenged mice had oral bacterial counts of approximately 108 CFU, in both 209 
cases similar to the parent mice. Similarly, whilst Streptococcus and Gemella genera dominated the 210 
oral microbiome of control parent and control litter mice, the major common components of the both 211 
challenged parents and their litter mice comprised Lactobacillus and Staphylococcus along with the 212 
Streptococcus and Gemella genera. The transmission of either control or dysbiotic oral microbial 213 
populations was also reflected in the periodontal bone loss of the respective litters. The litters of 214 
challenged mice displayed significantly elevated periodontal bone loss (0.005 mm/week; p<0.001) 215 
compared to the litter of control mice (0.002 mm/week). 216 
Dysbiosis of the mouse oral microbiome is stable to antibiotic treatment 217 
The preceding transfer experiments indicated that the DysPg microbiome is not only stable over time 218 
but also able to stably transfer both vertically and horizontally into healthy recipient animals and 219 
recapitulate the disease experience of the donor mice. As a further measure of stability, we next 220 
examined the influence of antibiotic treatment on dysbiosis induced by P. gingivalis. Control and P. 221 
gingivalis challenged C3H/Orl mice were placed on antibiotics in the drinking water 7 days after the 222 
challenge. Antibiotic treatment was continued for 10 days and then both groups of mice were 223 
returned to normal drinking water (Fig 5). Control animals carried approximately 107 CFU of oral 224 
bacteria at the start of the experiment compared to 108 CFU in challenged mice. Seven days following 225 
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the end of treatment with antibiotics, the counts in both groups were significantly reduced to the 226 
same level of approximately 106 CFU. Gemella in the control group and Gemella and organisms of the 227 
genus Bacteroides in the challenged mice appeared most susceptible to antibiotic treatment.  228 
However, at 16 and 22 weeks post antibiotic treatment the bacterial counts in both control and 229 
challenged mice were restored to the pre-antibiotic treatment levels (Fig 5). The recovery in counts 230 
was accompanied by the re-emergence of the Gemella to the original levels by 22 weeks and the 231 
appearance of Enterobacteriaceae in both groups. Bacteroides was not restored to the pre-antibiotic 232 
levels in the challenged mice but organisms from the genus Enterococcus were detected at 22 weeks 233 
post antibiotic treatment in these animals. Thus, this regimen of antibiotic treatment had only a 234 
temporary suppressive effect on the elevated counts of the DysPg microbiome and its composition. 235 
The overall population structures at 16 and 22 weeks post antibiotic cessation were not significantly 236 
different to the pre-treatment populations. (Fig 5, Appendix Table 4 & 5).  237 
Discussion 238 
 239 
In this study, we demonstrate for the first time, the stability of a dysbiotic oral microbiome over time 240 
and transfer across individuals and generations and the ability of this perturbed microbial community 241 
to drive destructive periodontal bone loss in previously healthy, recipient animals. The mouse oral 242 
gavage model (Baker et al. 2000) has been used extensively to investigate host-microbe interactions 243 
in periodontal disease. Routinely these studies have measured microbial and immune parameters and 244 
alveolar bone loss at a single time point six weeks post challenge (Hajishengallis et al. 2011, Polak et 245 
al. 2009). In the current investigations, we only report periodontal bone loss as an indicator of 246 
periodontal disease although we also established that the gavage methodology did lead to loss of 247 
periodontal soft tissue attachment and an increase in inflammatory cell recruitment into the 248 
periodontal tissues of challenged mice (Supplementary figure 1).  249 
Longitudinal assessment of the microbiology and bone levels over 28 weeks post challenge 250 
demonstrate that following introduction of P. gingivalis, community wide perturbation of the 251 
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commensal microbiome is maintained for the entire experimental period and is accompanied by 252 
alveolar bone loss at a rate equivalent to that observed in the initial six-week period. Hence, 253 
development and maintenance of changes to the oral microbial community structure were temporally 254 
aligned to the initiation and progression of bone loss. 255 
 256 
Although this coherence between oral microbial dysbiosis and bone loss is consistent with causation, 257 
as with human periodontitis, coherence fails to discriminate between causation versus a 258 
consequential relationship in which the presence of disease simply maintains the environmental 259 
conditions which favour alterations to the microbial populations.  More definitive evidence for a causal 260 
link was established in the horizontal and vertical transfer experiments. In both experimental 261 
approaches, the altered oral microbiome, initially generated by P.  gingivalis challenge, transferred 262 
unchanged into healthy recipient animals and was accompanied by the development of bone loss 263 
equivalent to that observed in donor animals. In so doing, the dysbiotic community acts like a 264 
conventional transmissible infectious disease agent with concomitant effects on pathology. 265 
 266 
Previous investigations (Hajishengallis et al.  2011) demonstrated that the presence of the commensal 267 
microbiome was fundamental to the development of disease since whilst gavage of SPF mice leads to 268 
periodontal bone loss, mono-colonisation of germ-free animals with P. gingivalis is asymptomatic. We 269 
suggested that this phenomenon may be a consequence of the immune subversive properties of this 270 
human periodontal organism (Hajishengallis et al. 2012, Maekawa et al. 2014) which has the ability to 271 
change the delicate equilibrium between the microbiota and the host in the oral tissues and facilitate 272 
the conversion of the normally benign commensal microbiota to a more pathogenic state. That these 273 
changes occurred even when P. gingivalis was present in low amounts, led us to invoke the keystone 274 
pathogen hypothesis (Hajishengallis et al. 2012) wherein a low abundance species can have 275 
disproportionately large effects on the balance between symbiosis and dysbiosis and simultaneous 276 
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impact on pathology.  Similarly, very low levels of P. gingivalis in challenged mice were also observed 277 
in the current investigation. 278 
However, rather than a keystone pathogen effect, it is also possible to argue that the oral gavage 279 
procedure itself, which routinely uses very high doses of P. gingivalis, is the fundamental trigger for 280 
disease by eliciting very significant alterations to the local oral immune and inflammatory status of the 281 
mouse at the time of challenge. As a consequence, a changed environment may be generated which 282 
would facilitate overgrowth and reconfiguration of the commensal microbial community structure 283 
and, through this, the development of bone loss. Indeed, analysis of a number of components of the 284 
immune and inflammatory system in the gingival tissues of immediately post-challenged mice support 285 
the deleterious effects of the oral gavage process. (Hajishengallis et al. 2011). It is therefore 286 
acknowledged that the P. gingivalis gavage murine model has some limitations with respect to its 287 
relationship to human disease.  However, in the experiments reported here, transfer of the dysbiotic 288 
microbiome from a P. gingivalis challenged SPF mouse into a healthy recipient mouse results in the 289 
same levels of oral microbial load, microbial population structure and destructive bone loss as that 290 
experienced by the originally challenged mice. In so doing, these results demonstrate unequivocally 291 
that the potentially detrimental effects of high dose P. gingivalis challenge are not required to 292 
establish disease:  alveolar bone loss is solely the consequence of acquisition of the dysbiotic oral 293 
microbial community independent of gavage.  294 
The longitudinal analysis of challenged mice, the stability of the dysbiotic microbiome to antibiotic 295 
treatment and the horizontal and vertical transfer experiments all emphasise the pronounced 296 
resilience of the dysbiotic community structure induced by gavage with P. gingivalis.  Such resilience 297 
has also been reported during longitudinal analysis of the human oral microbiome in health. For 298 
example, analysis of the salivary microbiome of two individuals on a daily basis over the course of one 299 
year demonstrated a highly stable microbial community structure which appeared far more resilient 300 
to alterations than the corresponding gut microbial populations in the same individuals. (David et al. 301 
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2014). The oral microbiome of adolescents appeared remarkably resilient to change over time during 302 
orthodontic treatment (Koopman et al. 2015) and similar stability was found in the oral microbiome 303 
of healthy adults following antibiotic administration (Zaura et al. 2015). Although the stability of 304 
human oral microbial populations in disease has received less attention, the data in the present 305 
murine investigation suggest that dysbiotic oral microbial communities can also display pronounced 306 
resilience behaviour and this can have a significant bearing on the development and progression of 307 
periodontal disease.  308 
It is recognised that the stability of a microbial community is not simply maintained by inertia, but by 309 
the action of restoring forces within a dynamic system (Relman DA 2012). In the case of the oral 310 
microbiome, these may include a complex set of metabolic and functional interrelationships that 311 
develop within dental biofilms and between biofilms and the host (Rosier et al. 2018).  Understanding 312 
the nature of the parameters which underpin the resilience of healthy and dysbiotic microbial 313 
populations may be important to the development of approaches to prevent the progress of disease 314 
and to restore health in diseased individuals. 315 
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 406 
Fig 1. P. gingivalis mediated dysbiosis is stable over time and associated with long term destructive 407 
disease in the murine model: (A) Bacterial composition of the oral microbiome, determined by culture, 408 
of control and P. gingivalis treated mice at 16 weeks (C/16 & Pg/16), 22 weeks (C/22 & Pg/22) and 28 409 
weeks (C/28 & Pg28). The sizes of the pie-charts are indicative of the variations in the total oral 410 
bacterial counts in the different groups. The graphs have been plotted using the observed number of 411 
CFUs of each microorganism in each group. Statistical significance in the differences between the 412 
microbial communities at each time point was determined by PERMANOVA analysis (** p<0.05; *** 413 
p<0.005; **** p<0.0005) (B) Total oral bacterial counts in the different groups expressed as log10 of 414 
CFUs. (C) Alveolar bone levels at 16, 22 and 28 weeks in control and P. gingivalis treated mice. Bone 415 
loss was expressed as negative values relative to the baseline. Each point represents the mean bone 416 
level for an individual mouse with horizontal lines representing the mean bone levels per group +/- 417 
SD. The dotted line represents the linear rate of bone loss in P. gingivalis treated mice over time (** 418 
p<0.05; *** p<0.005; **** p<0.0005). 419 
 420 
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 421 
Fig 2. Longitudinal comparison of oral microbial population analyses of control and P. gingivalis 422 
challenged mice at 16, 22 and 28 weeks by laboratory culture followed by full length 16S rRNA gene 423 
sequencing (red) and Roche 454 next generation sequencing (NGS) methodology of the V1-V3 region 424 
of the 16S rRNA genes (blue). The predominant genera observed in the populations have been listed 425 
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on the X axis while the Y axis represents the relative abundance of the bacterial genera in the individual 426 
populations expressed in percentages.  427 
 428 
 429 
Fig 3.  P. gingivalis mediated dysbiotic microbiomes stably transfer horizontally into healthy germ-free 430 
mice and lead to periodontal disease in the recipients: (A) Bacterial composition of the oral 431 
microbiome, determined by culture in control and P. gingivalis treated C3H/Orl mice (Ctrl & Pg) and 432 
conventionalized germ-free mice of identical genotype (CNV) co-caged with the P. gingivalis 433 
challenged mice for 14 days. The sizes of the pie-charts are indicative of the variations in the total oral 434 
bacterial populations in the different groups. The graphs have been plotted using the observed 435 
number of CFUs of each organism in each group. Statistical significance in the differences between 436 
the microbial communities of each group was determined by PERMANOVA analysis (** p<0.05; *** 437 
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p<0.005; **** p<0.0005) (B) Total oral bacterial counts expressed as log10 of CFUs in control and P. 438 
gingivalis treated mice and germ-free (GF) mice conventionalized by co-caging with the challenged 439 
mice. (C) Alveolar bone levels in germ-free, control (unchallenged), P. gingivalis challenged and 440 
conventionalized germ-free mice (CNV) determined after 16 weeks of co-caging. Bone loss was 441 
expressed as negative values relative to the baseline. Each point represents the mean bone level for 442 
an individual mouse with horizontal lines representing the mean bone levels per group +/- SD. (** 443 
p<0.05; *** p<0.005; **** p<0.0005) 444 
 445 
 446 
 447 
Fig 4. Inter-generational transfer of P. gingivalis mediated dysbiotic microbiomes and vertical 448 
transmission of disease: (A) Bacterial composition of the oral microbiome, determined by culture, of 449 
control and Pg treated parents at 16 weeks (C/16 & Pg/16) and litters of controls and Pg treated 450 
parents at 8 (FC/8 & FPg/8), 16 (FC/16 & FPg/16) and 28 weeks (FC/28 & FPg/28). The sizes of the pie-451 
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charts are indicative of the variations in the total oral bacterial counts in the different groups. The 452 
graphs have been plotted using the observed number of CFUs of each organism in each group. 453 
Statistical significance in the differences between the microbial communities at each time point was 454 
determined by PERMANOVA analysis (** p<0.05; *** p<0.005; **** p<0.0005) (B)  Total oral bacterial 455 
counts expressed as log10 of CFUs in the parents (C/16 & Pg/16) and litters at 8 (FC/8 & FPg/8), 16 456 
(FC/16 & FPg/16) and 28 weeks (FC/28 & FPg/28). (C) Alveolar bone levels at 16 (C/16 & Pg/16) and 457 
28 (C/28 & Pg/28) weeks in control and P. gingivalis treated parents and litters at 16 (FC/16 & FPg/16) 458 
and 28 (FC/28 & FPg/28) weeks. Bone loss was expressed as negative values relative to the baseline. 459 
Each point represents the mean bone level for an individual mouse with horizontal lines representing 460 
the mean bone levels per group +/- SD. (** p<0.05; *** p<0.005; **** p<0.0005) 461 
 462 
 463 
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Fig 5. Dysbiosis of the mouse oral microbiome is stable to antibiotic treatment: (A) Bacterial 464 
composition of the oral microbiome, determined by culture, of control and Pg treated mice (C & Pg), 465 
pre-antibiotics (C/T0 & Pg/1), immediately post-antibiotics (C/Abs & Pg/Abs) and at 8, 16 and 22 weeks 466 
post antibiotics (C/8, C/16, C/22 & Pg/8, Pg/16, Pg/22). The sizes of the pie-charts are indicative of the 467 
variations in the total oral bacterial counts in the different groups. The graphs have been plotted using 468 
the observed number of CFUs of each organism in each group. Statistical significance in the differences 469 
between the microbial communities at each time point was determined by PERMANOVA analysis (** 470 
p<0.05; *** p<0.005; **** p<0.0005) (B) Total oral bacterial counts (as a measure of the dysbiosis) in 471 
the different groups expressed as log10 of the CFUs. (** p<0.05; *** p<0.005; **** p<0.0005) 472 
 473 
 474 
 475 
